Steven Kelly - Jan 28, 2025 Form 4 Insider Report for Carisma Therapeutics Inc. (CARM)

Role
President and CEO, Director
Signature
/s/ Steven Kelly
Stock symbol
CARM
Transactions as of
Jan 28, 2025
Transactions value $
$0
Form type
4
Date filed
1/30/2025, 04:01 PM
Previous filing
Dec 23, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CARM Stock Option (Right to Buy) Award $0 +500K $0.00 500K Jan 28, 2025 Common Stock 500K $0.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest over four years in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.